Laboratorios Sophia S.A de C.V.: Dry Eye Syndromes trials

The registry lists 13 Dry Eye Syndromes studies with Laboratorios Sophia S.A de C.V. as lead sponsor. 2 are open to participants now and 10 have results posted.

Phase 1 8Phase 2 3Phase 3 1Phase 4 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.Not yet recruitingNCT06379685Phase 1
• Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®Not yet recruitingNCT06375343Phase 1
• Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.CompletedNCT04704531Phase 2Results posted
• Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.CompletedNCT04702776Phase 4Results posted
• Clinical Trial to Compare the Safety and Efficacy of Nanodrop®CompletedNCT04111965Phase 1/2Results posted
• Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic SolutionCompletedNCT04081610Phase 1Results posted
• Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime GelCompletedNCT03697876Phase 1Results posted
• Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy SubjectsCompletedNCT03524157Phase 1Results posted
• Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.CompletedNCT03520348Phase 1Results posted
• Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)CompletedNCT03223909Phase 4Results posted
• Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry EyeCompletedNCT01657253Phase 3Results posted
• Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye SyndromeCompletedNCT01541891Phase 2Results posted
• Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PFCompletedNCT06370585Phase 1